FDA panel votes for Pfizer booster for those 65+ and at higher risk

Meg Tirrell joins Closing Bell with breaking news. An FDA advisory committee voted to approve an emergency authorization for a booster dose of Pfizer's covid vaccine for those 65 and older. This is just minutes after the committee voted not to approve the boosters for all people over 16 years old.
Fri, Sep 17 20214:42 PM EDT